Publicaciones en las que colabora con ANTONIO JOSÉ LÓPEZ FARRE (12)

2013

  1. Platelet content of nitric oxide synthase 3 phosphorylated at serine 1177 is associated with the functional response of platelets to aspirin

    PLoS ONE, Vol. 8, Núm. 12

2012

  1. Plasma desmoplakin I biomarker of vascular recurrence after ischemic stroke

    Journal of Neurochemistry, Vol. 121, Núm. 2, pp. 314-325

2011

  1. Dronedarone

    Drugs of Today, Vol. 47, Núm. 2, pp. 109-133

  2. Proteomic changes related to "bewildered" circulating platelets in the acute coronary syndrome

    Proteomics, Vol. 11, Núm. 16, pp. 3335-3348

2010

  1. Old and new molecular mechanisms associated with platelet resistance to antithrombotics

    Pharmaceutical Research, Vol. 27, Núm. 11, pp. 2365-2373

2009

  1. Omecamtiv mecarbil. Cardiac myosin activator treatment of heart failure

    Drugs of the Future, Vol. 34, Núm. 12, pp. 950-961

2008

  1. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients

    Proteomics - Clinical Applications, Vol. 2, Núm. 9, pp. 1300-1312

  2. Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1)

    Cardiovascular Research, Vol. 80, Núm. 3, pp. 375-384

  3. The HERACLES cardiovascular network

    Revista Espanola de Cardiologia, Vol. 61, Núm. 1, pp. 66-75

2006

  1. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism

    Cardiovascular Research, Vol. 72, Núm. 1, pp. 80-89

  2. Proteomic study of plasma from moderate hypercholesterolemic patients

    Journal of Proteome Research, Vol. 5, Núm. 9, pp. 2301-2308

2005

  1. Soluble guanylyl cyclase during postnatal porcine pulmonary maturation

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 288, Núm. 1 32-1